To wait, or too late? modeling the effects of delayed Ofatumumab treatment in relapsing-remitting Multiple Sclerosis
CONCLUSIONS: The DES model provided a means by which the magnitude of benefit associated with earlier ofatumumab initiation could be quantified; fewer relapses and a prolonged time to wheelchair were predicted.PMID:36546701 | DOI:10.1080/13696998.2022.2161746
Source: Journal of Medical Economics - Category: Health Management Authors: Stephen Maxwell Montgomery Luke Green Hajer Karoui Richard Nicholas Jaclyn Loh Source Type: research